These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 15556265

  • 1. Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease.
    Reimund JM, Arondel Y, Joly F, Messing B, Duclos B, Baumann R.
    Clin Nutr; 2004 Dec; 23(6):1418-25. PubMed ID: 15556265
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome.
    Hallikainen M, Huikko L, Kontra K, Nissinen M, Piironen V, Miettinen T, Gylling H.
    Nutr Clin Pract; 2008 Dec; 23(4):429-35. PubMed ID: 18682596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
    de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.
    JPEN J Parenter Enteral Nutr; 2009 Dec; 33(5):541-7. PubMed ID: 19571170
    [Abstract] [Full Text] [Related]

  • 6. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
    Burns DL, Gill BM.
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [Abstract] [Full Text] [Related]

  • 8. Hepatic cytolytic and cholestatic changes related to a change of lipid emulsions in four long-term parenteral nutrition patients with short bowel.
    Gerard-Boncompain M, Claudel JP, Gaussorgues P, Salord F, Sirodot M, Chevallier M, Robert D.
    JPEN J Parenter Enteral Nutr; 1992 Mar; 16(1):78-83. PubMed ID: 1346655
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP, Teitelbaum DH.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [Abstract] [Full Text] [Related]

  • 11. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [Abstract] [Full Text] [Related]

  • 12. Some new insights in intestinal failure-associated liver disease.
    Goulet O, Joly F, Corriol O, Colomb-Jung V.
    Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
    [Abstract] [Full Text] [Related]

  • 13. Olive oil in parenteral nutrition.
    Sala-Vila A, Barbosa VM, Calder PC.
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):165-74. PubMed ID: 17285004
    [Abstract] [Full Text] [Related]

  • 14. Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure.
    Thomas-Gibson S, Jawhari A, Atlan P, Brun AL, Farthing M, Forbes A.
    Clin Nutr; 2004 Aug; 23(4):697-703. PubMed ID: 15297108
    [Abstract] [Full Text] [Related]

  • 15. Nutritional management of infants with short bowel syndrome.
    Wessel JJ, Kocoshis SA.
    Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
    Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M.
    Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
    Ekema G, Falchetti D, Boroni G, Tanca AR, Altana C, Righetti L, Ridella M, Gambarotti M, Berchich L.
    J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.